Financials
Value Q1, 25Q2, 25 TTM Selling/general/admin expenses —— — Research & development —— — Operating income -3.05 M-3.22 M -27.59 M Non-Operating Income, Total -278 K7 000 -1.28 M Interest expense, net of interest capitalized 435 K386 K 1.88 M Non-Operating Income, excl. Interest Expenses -435 K-386 K -1.88 M Unusual income/expense 157 K393 K 602 K Pretax income -3.33 M-3.21 M -28.86 M Equity in earnings —— — Taxes -1.39 M7 000 -1.25 M Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations -1.94 M-3.22 M -27.61 M Discontinued operations —— — Net income -1.94 M-3.22 M -27.61 M Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders -1.94 M-3.22 M -27.61 M Basic earnings per share (Basic EPS) -0.3-0.43 -3.96 Diluted earnings per share (Diluted EPS) -0.3-0.43 -3.96 Average basic shares outstanding 6.86 M7.58 M — Diluted shares outstanding 6.86 M7.58 M — EBITDA 1.33 M— — EBIT -3.05 M-3.22 M -27.59 M Cost of revenue 89.02 M90.58 M 345.58 M Other cost of goods sold —— — Depreciation & amortization (cash flow) 4.39 M4.4 M 19.12 M